Search alternatives:
"cost-consequence analysis" » "most-consequence analysis" (Expand Search), "post-consequence analysis" (Expand Search)
Showing 1 - 1 results of 1 for search '"cost-consequence analysis"', query time: 0.07s Refine Results
  1. 1
    THE USE OF PALBOCKLIB, A CYCLINE-DEPENDENT KINASE 4/6 INHIBITOR, IN THE TREATMENT OF METASTATIC BREAST CANCER. A COST-CONSEQUENCE ANALYSIS

    THE USE OF PALBOCKLIB, A CYCLINE-DEPENDENT KINASE 4/6 INHIBITOR, IN THE TREATMENT OF METASTATIC BREAST CANCER. A COST-CONSEQUENCE ANALYSIS by S. L. Pavlinsky, P. I. Shabalkin

    Published 2017-09-01
    Subjects:
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: